Can-Fite Biopharma CANF
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 4 | 6 | 10 | |||
| 2025Q2 | 21 | 4 | 8 | |||
| 2024Q4 | 32.5 | 5 | 9 | |||
| 2024Q2 | 51.6 | 2 | 6 | |||
| 2023Q4 | 44 | 6 | -28.79 | -2 | -17.25 | 10 |
| 2023Q3 | 53 | 5 | -29.1 | -2 | -17.44 | 9 |
| 2023Q2 | 61.4 | 7 | -21.73 | -2 | -13.62 | 11 |
| 2023Q1 | 45.8 | 8 | -39.34 | -3 | -22.4 | 13 |
| 2022Q4 | 122.6 | 4 | -50.74 | -3 | -27.46 | 9 |
| 2022Q3 | 153.98 | 7 | -29.2 | -3 | -18.42 | 13 |
| 2022Q2 | 184 | 10 | -19.99 | -2 | -13.44 | 15 |
| 2022Q1 | 248 | 12 | -18.44 | -2 | -12.78 | 18 |
| 2021Q4 | 258 | 14 | -34.73 | -4 | -23.6 | 20 |
| 2021Q3 | 332 | 9 | -51.17 | -3 | -27.96 | 15 |
| 2021Q2 | 456 | 4 | -18.83 | -3 | -14.82 | 10 |
| 2021Q1 | 494 | 30 | -39 | -208.7 | 34 | |
| 2020Q4 | 356 | -4 | 2 | 46.7 | 3 | |
| 2020Q3 | 354 | -6 | -3 | -29.89 | 7 | |
| 2020Q2 | 396 | -3 | -4 | -29.77 | 14 | |
| 2020Q1 | 262 | -4 | -4 | 11 |